COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,796 Articles (22,527 medRxiv, 8,269 bioRxiv)

Most recent first Previous |  Page 1369: Articles 13681-13690  | Next

The SARS-CoV-2 host cell membrane fusion protein TMPRSS2 is a tumor suppressor and its downregulation correlates with increased antitumor immunity and immunotherapy response in lung adenocarcinoma
Liu, Z., Zhang, Z., Feng, Q., Wang, X.
10.1101/2021.06.30.450490 — Posted: 2021-06-30
Varenicline Prevents SARS-CoV-2 Infection In Vitro and in Rhesus Macaques
Nau, J., Luthra, P., Lanzer, K., Szaba, F., Cookenham, T., Carlson, E.
10.1101/2021.06.29.450426 — Posted: 2021-06-30
Large scale screening discovers clofoctol as an inhibitor of SARS-CoV-2 replication that reduces COVID-19-like pathology
Belouzard, S., Machelart, A., Sencio, V., Vausselin, T., Hoffmann, E., Deboosere, N., Rouille, Y., Desmarets, L., Seron, K., Danneels, A., Robil, C., Belloy, L., Moreau, C., Piveteau, C., Biela, A., Vandeputte, A., Heumel, S., Deruyter, L., Dumont, J., Leroux, F., Engelmann, I., Alidjinou, E. K., Hober, D., Brodin, P., Beghyn, T., Trottein, F., Deprez, B., Dubuisson, J.
10.1101/2021.06.30.450483 — Posted: 2021-06-30
Pathology and immunity after SARS-CoV-2 infection in male ferrets is affected by age and inoculation route
van de Ven, K., van Dijken, H., Wijsman, L., Gomersbach, A., Schouten, T., Kool, J., Lenz, S., Roholl, P., Meijer, A., van Kasteren, P., de Jonge, J.
10.1101/2021.06.30.450298 — Posted: 2021-06-30
Classifying COVID-19 variants based on genetic sequences using deep learning models
Basu, S., Campbell, R. H.
10.1101/2021.06.29.450335 — Posted: 2021-06-30
Epitope order Matters in multi-epitope-based peptide (MEBP) vaccine design: An in silico study
Salaikumaran, M. R., Kasamuthu, P. S., Burra, V. L. S. P.
10.1101/2021.06.29.450372 — Posted: 2021-06-30
Early detection of SARS-CoV-2 in circulating immune cells in a mouse model
Geng, T., Keilich, S., Tafas, F., WANG, P.
10.1101/2021.06.30.450531 — Posted: 2021-06-30
Highly-Neutralizing COVID-19-Convalescent-Plasmas Potently Block SARS-CoV-2 Replication and Pneumonia in Syrian Hamsters.
Takamatsu, Y., Imai, M., Maeda, K., Nakajima, N., Higashi-Kuwata, N., Iwatsuki-Horimoto, K., Ito, M., Kiso, M., Maemura, T., Takeda, Y., Omata, K., Suzuki, T., Kawaoka, Y., Mitsuya, H.
10.1101/2021.06.29.450453 — Posted: 2021-06-30
Comparative computational modeling of the bat and human immune response to viral infection with the Comparative Biology Immune Agent Based Model
Cockrell, C., An, G.
10.1101/2021.06.29.450378 — Posted: 2021-06-30
Relating in vitro neutralisation level and protection in the CVnCoV (CUREVAC) trial.
Cromer, D., Reynaldi, A., Steain, M., Triccas, J. A., Davenport, M. P., Khoury, D. S.
10.1101/2021.06.29.21259504 — Posted: 2021-06-30

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).